Chinese herbal medicines market lasts fatigued and weak a variety of medicinal material price near the freezing point

Since 2011 May the state for adjusting structure, steady growth, maintaining stability, by the economic policy fine-tuning draw watershed, the high prices have been effectively curbed. Medicinal material price also went back, from soaring to stagnation to ebb. Starting in May of this year the market of the medicinal material in drug quality adulteration makes false and operating order special rectification, successive adjustment and examination also prevented because of overheating investment leads to bubble economy.

A variety of medicinal material price closer to the " freezing point "

Recently, the country's largest Chinese herbal medicine market in Anhui Bozhou trading hall of the Chinese herbal medicine prices are falling, in addition to three seven and a few varieties of Cordyceps sinensis in rose, more than 80% Chinese herbal medicines on sale, like Atractylodes price fell 70%. Atractylodes macrocephala highest price in 60 ~ 70 yuan / kg, currently only maintained at 20 yuan / kg. Estimation of new money appears on the market also continued to fall, about 15 yuan / kg.

Atractylodes macrocephala is easy to grow, but not easy to store, so prices have immediate sale. Over the past ten years Atractylodes price changes, showing a pronounced cyclical fluctuations, 2005 is about 14 yuan / kg, a road in 2007 rose to 56 yuan / kg of, over 3 times more. In 2008 fell to 13～ 14 yuan / kilogram. And again in 2010 increased to almost 50 yuan / kilogram, broke up nearly 3 times, after a decline, has returned to 18 yuan / kg lower and upper position, basically be a roller-coaster ride.

Another kind of Chinese herbal medicine angelica, price fluctuations larger. In the middle of 2009 started to go up, up to the early 2011 17 yuan / kg, was over 5 times more. Mid 2011 begins to shake down, now basically in 10 yuan / kg.

Coptis root, tuckahoe, day Ma and wild chrysanthemum in Hubei province is an important Chinese characteristics of varieties. In 2009 the Chinese herbal medicine price surges, Rhizoma Coptidis and tuckahoe value rise directly to a high position, respectively, rose to 120 yuan / kg and 30 yuan / kg, days of ramie price has been as high as 300 yuan / kilogram, No Kikuka price also had more than 20 yuan / kilogram.

At present, Rhizoma Coptidis and tuckahoe price has dropped to 50 yuan / kg and 15 yuan / kg, more than 50 percent shrink, day Ma is dropped to 18 yuan / kg, No Kikuka price also fell to 12 yuan / kg.

Chinese herbal medicine prices, Pseudostellaria is fully deserve "leading sheep ". Since 2009, prince ginseng price from 30 yuan / kg over a dozen times even, its price was as high as 600 yuan per kg, let buyers and step back, not only once in a hospital pharmacy disappear, even as the main raw materials production to Pseudostellaria Jianweixiaoshi Tablets in there is restricted to produce news.

Now, prince ginseng price all the way down to 180 yuan / kg. In addition, the price from 10 yuan / kilogram directly turned to the highest point of 35 yuan / kg of chuanxiong and from 40 yuan / kg rose to 150 yuan / kg of Ophiopogon japonicus, is in this year was beaten back. " ". At present, the market of the medicinal material in Chuanxiong price is maintained be in 10 yuan / kg, Ophiopogon japonicus is back to 35 yuan / kg.

Unbearable burden

High jump on the bandwagon, fell to coax and is the cause of these agricultural products price is acuteness and fluctuant main reason. Chinese herbal medicine digestive main channel the first pharmaceutical companies, but from May this year medical fair exports, extracts of Chinese medicine, Chinese herbal medicine, Chinese medicine and many other categories of products turnover compared to the same period last year were decreased in different degree. At the same time, the domestic production of sharp cut, pharmaceutical enterprises predicament on medicinal material market lasts fatigued and weak produce bigger effect, the reason mainly lies in the following aspects:

This year the European debt crisis is due to a worsening economy increases fast fall after a rise significantly, China and some countries international tensions between medicine export market, has displayed the policy barriers, lack of external demand is more outstanding, extract and herbal medicine exports have declined. The present exchange rate changes will make the export business interests. Therefore, some foreign processing enterprises to reduce raw material purchase.

Two with labor, the production cost of raw materials, to rise considerably, profit decline. Because the downstream enterprise funds advanced slowly, so that enterprises limited funds more difficult, for funds flow, pharmaceutical companies had to take to reduce raw material inventory.

Three is in raw material prices, health care effect in advance, for squeezing out the unreasonable prices, national medical insurance basic medical prices, manufacturers also subtract the production and reduce raw material purchase.

Four is with the market for adulteration makes false produced fake drug crackdown, the pharmaceutical companies to reduce product inventory, in order to avoid adverse situation appears in the examination, increase the punishment cost. While summer is the best season to repair machines, therefore, pharmaceutical companies are only guaranteed supply of baseline inventory, reduce material and product backlog.

To sum up, along with the rising cost of pharmaceutical companies, operating pressure continued to increase, in the lower end of the domestic pharmaceutical enterprises are facing increasingly fierce competition as well as the pharmaceutical industry upgrading, the overall after the potential purchasing power in the market and is apparently insufficient, production inventory herbs not been good digestion, market is fatigued and weak, the price glides situation will still continue. By the early high stimulation restores grown herbs this year until next year will usher in the new, now part of medicinal material price is small rise in overall medical city has no role in adding fuel to the flames, market outlook is not optimistic.